Aurora Cannabis Inc. (ACB) vs Lifecore Biomedical, Inc. (LFCR)

Aurora Cannabis Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. and Lifecore Biomedical, Inc. are of similar size ($265.8M and $244.1M). Lifecore Biomedical, Inc. grew revenue faster over the last twelve months: −10.0% against −18.2%. Lifecore Biomedical, Inc. has the higher net margin (−37.5% vs −38.1%) and the higher return on invested capital (−2.80% vs −5.58%). Across the 17 metrics below, Lifecore Biomedical, Inc. leads on 10 and Aurora Cannabis Inc. on 7.

Valuation

Metric ACB LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.17 2.00 2.11
P/B 0.65 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.93 3.41 2.73
Earnings yield (35.34%) (15.20%) (4.38%)
Free cash flow yield (14.67%) (2.11%) 0.00%

Profitability

Metric ACB LFCR Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 26.86% 53.94%
Operating margin (12.13%) (6.89%) 0.00%
Net margin (38.12%) (37.54%) 0.00%
Free cash flow margin (17.19%) (4.24%) 0.00%
Return on equity (19.85%) 201.15% (0.40%)
Return on assets (15.19%) (19.32%) (3.32%)
Return on invested capital (5.58%) (2.80%) 0.00%

Growth

Metric ACB LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) (10.03%) 10.01%
EPS growth (last fiscal year) (5,266.67%) (439.33%) 49.06%
Revenue growth, 5-year CAGR 3.92% (4.24%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 11.50 0.05
Current ratio 5.36 3.87 2.31
Net debt to EBITDA 5.11 (15.59) 0.97

Dividend

Metric ACB LFCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ACB LFCR Drug Manufacturers Specialty & Generic median
Market cap 265.84m 244.12m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack